Amy W. Veenhuizen
Pfizer (United States)(US)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Synthesis and biological activity, Synthesis of β-Lactam Compounds, Synthesis and Reactions of Organic Compounds, Estrogen and related hormone effects
Most-Cited Works
- → Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)(1997)1,949 cited
- → Characterization of the Cytoprotective Action of Peroxynitrite Decomposition Catalysts(1998)230 cited
- → 1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2(1997)169 cited
- → 1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents(1997)153 cited
- → Selective Cyclooxygenase-2 Inhibitors: Heteroaryl Modified 1,2-Diarylimidazoles Are Potent, Orally Active Antiinflammatory Agents(2000)111 cited
- → Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2(1995)79 cited
- → Diarylspiro[2.4]heptenes as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors: Synthesis and Structure−Activity Relationships(1996)58 cited
- → 3,4-diarylpyrazoles: Potent and selective inhibitors of cyclooxygenase-2(1997)16 cited
- Novel 1,2-diarylcyclopentenes are selective, potent, and orally active cyclooxygenase inhibitors(1995)
- → ChemInform Abstract: 1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents.(1996)5 cited